8-K Announcements
6Material company update
May 27, 2026·SEC
Material company update
May 20, 2026·SEC
Material company update
Apr 30, 2026·SEC
DNA X, Inc.(SONM)Earnings, Financials & Key Ratios
SONM•NASDAQ
Price updated Jun 19, 2026
SectorTechnologyIndustryCommunication EquipmentSub-IndustryPublic Safety and Mission-Critical Radios
AboutSonim Technologies, Inc. provides ruggedized mobile phones and accessories for task workers. The company offers ruggedized mobile phones, such as Sonim XP8, Sonim XP5s, Sonim XP3, and Sonim XP3plus based on the Android platform that are capable of attaching to public and private wireless networks; industrial-grade accessories, including remote speaker microphones, multi-bay charging accessories, and in-vehicle hands-free voice communications solutions; and cloud-based software and application services. It sells its mobile phones and accessories primarily to wireless carriers in the United States and Canada; and sells ruggedized phones, barcode scanners, and accessories through distribution channels in North America, South America, and Europe. The company serves transportation and logistics, construction, manufacturing, facilities management, energy and utility, and public sectors. The company was formerly known as NaviSpin.com, Inc. and changed its name to Sonim Technologies, Inc. in December 2001. Sonim Technologies, Inc. was incorporated in 1999 and is based in Austin, Texas.Show more
- Revenue$0-100.0%
- EBITDA-$1M+96.3%
- Net Income-$21M+38.6%
- EPS (Diluted)-1.59+77.7%
SONM Key Insights
DNA X, Inc. (SONM) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
No significant strengths identified
✗Weaknesses
- ✗Weak Piotroski F-Score: 2/9
- ✗Shares diluted 100.0% in last year
- ✗Trading more than 30% below 52-week high
- ✗Low asset turnover indicates capital-intensive operations
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when SONM posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
SONM Price & Volume
DNA X, Inc. (SONM) stock price & volume — 10-year historical chart
Loading chart...
SONM Growth Metrics
DNA X, Inc. (SONM) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years-
3 Years-
TTM-128.71%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM51.21%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-50.04%
Return on Capital
10 Years-126.03%
5 Years-139.14%
3 Years-167.96%
Last Year-
SONM Recent Earnings
DNA X, Inc. (SONM) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 3/12 qtrs (27%)●Beat Revenue 1/12 qtrs (10%)
Q2 2026Latest
May 20, 2026Metric
Actual
Est
EPS
$3.11-161.7%
$5.04
Rev
—
$35M
Q1 2026
Jan 30, 2026Metric
Actual
Est
EPS
$10.97-200.0%
$10.97
Rev
$44M-207.1%
$41M
Q4 2025
Oct 31, 2025Metric
Actual
Est
EPS
$3.86-171.5%
$5.40
Rev
$16M-52.8%
$34M
Q3 2025
Aug 8, 2025Metric
Actual
Est
EPS
$10.97-1623.6%
$0.72
Rev
$11M-61.6%
$29M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 20, 2026 | $3.11vs $5.04-161.7% | —vs $35M |
| Q1 2026 | Jan 30, 2026 | $10.97vs $10.97-200.0% | $44Mvs $41M-207.1% |
| Q4 2025 | Oct 31, 2025 | $3.86vs $5.40-171.5% | $16Mvs $34M-52.8% |
| Q3 2025 | Aug 8, 2025 | $10.97vs $0.72-1623.6% | $11Mvs $29M-61.6% |
Based on last 12 quarters of dataView full earnings history →
SONM Peer Comparison
DNA X, Inc. (SONM) competitors in Public Safety and Mission-Critical Radios — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 LIQT | 8.95M | 0.90 | -1.01 | 13.03% | -55.45% | -79.65% | 1.67 | |
 KOSS | 38.15M | 4.03 | -43.15 | 2.93% | -8.57% | -3.62% | 0.08 | |
 NTGR | 630.27M | 23.05 | -20.22 | 2.91% | -5.77% | -7.97% | 0.10 | |
 SMSI | 12.07M | 2.93 | -0.40 | -15.53% | -165.35% | -141.94% | 0.13 | |
 GSAT | 10.36B | 80.41 | -536.07 | 9.04% | -4.03% | -3.21% | 1.54 | |
 T | 153.71B | 22.01 | 7.24 | 2.71% | 16.92% | 16.85% | 1.35 | |
 VZ | 191.36B | 45.37 | 11.17 | 2.52% | 12.43% | 16.42% | 1.90 | |
 TMUS | 196.6B | 181.67 | 18.69 | 8.49% | 11.65% | 17.82% | 2.07 |
Compare SONM vs Peers
DNA X, Inc. (SONM) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
SONM Income Statement
DNA X, Inc. (SONM) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 59.03M | 135.66M | 116.25M | 63.99M | 54.57M | 69.83M | 93.63M | 58.3M | 0 | -16.72M |
Revenue Growth % | - | 129.82% | -14.31% | -44.95% | -14.72% | 27.96% | 34.09% | -37.74% | -100% | -128.71% |
Cost of Goods Sold | 38.72M | 87.58M | 81.74M | 48.78M | 48.16M | 58.2M | 74.31M | 48.38M | 4.3M | -4.07M |
COGS % of Revenue | 65.59% | 64.55% | 70.32% | 76.23% | 88.25% | 83.35% | 79.36% | 82.98% | - | - |
Gross Profit | 20.31M▲ 0% | 48.09M▲ 136.8% | 34.51M▼ 28.2% | 15.21M▼ 55.9% | 6.41M▼ 57.8% | 11.62M▲ 81.2% | 19.32M▲ 66.3% | 9.92M▼ 48.7% | -4.3M▼ 143.3% | -12.66M▲ 0% |
Gross Margin % | 34.41% | 35.45% | 29.68% | 23.77% | 11.75% | 16.65% | 20.64% | 17.02% | - | 75.69% |
Gross Profit Growth % | - | 136.76% | -28.24% | -55.92% | -57.83% | 81.21% | 66.26% | -48.66% | -143.35% | - |
Operating Expenses | 27.08M | 42.7M | 56.89M | 44.47M | 44.41M | 25.91M | 18.81M | 43.56M | 1.11M | -2.99M |
OpEx % of Revenue | 45.88% | 31.47% | 48.94% | 69.49% | 81.39% | 37.11% | 20.09% | 74.72% | - | - |
Selling, General & Admin | 14.07M | 19.45M | 30.09M | 26.71M | 26.72M | 17.94M | 17.04M | 25.35M | 5.41M | 2.95M |
SG&A % of Revenue | 23.84% | 14.34% | 25.88% | 41.73% | 48.96% | 25.69% | 18.2% | 43.48% | - | - |
Research & Development | 13.01M | 23.25M | 26.06M | 16.22M | 17.7M | 7.97M | 1.77M | 14.23M | 0 | 3.81M |
R&D % of Revenue | 22.04% | 17.14% | 22.42% | 25.34% | 32.43% | 11.42% | 1.89% | 24.42% | - | - |
Other Operating Expenses | 0 | 0 | 736K | 1.55M | 0 | 0 | 0 | 3.98M | -4.3M | -1000K |
Operating Income | -6.77M▲ 0% | 5.39M▲ 179.7% | -22.38M▼ 514.9% | -29.26M▼ 30.7% | -38M▼ 29.9% | -14.29M▲ 62.4% | 513K▲ 103.6% | -33.64M▼ 6657.3% | -5.41M▲ 83.9% | -9.67M▲ 0% |
Operating Margin % | -11.47% | 3.98% | -19.25% | -45.72% | -69.64% | -20.46% | 0.55% | -57.7% | - | 57.83% |
Operating Income Growth % | - | 179.68% | -514.92% | -30.74% | -29.87% | 62.4% | 103.59% | -6657.31% | 83.93% | - |
EBITDA | -5.45M | 7.24M | -18.86M | -26.53M | -35.87M | -11.91M | 2.72M | -30.08M | -1.11M | -6.42M |
EBITDA Margin % | -9.24% | 5.34% | -16.22% | -41.46% | -65.74% | -17.06% | 2.9% | -51.6% | - | 38.42% |
EBITDA Growth % | - | 232.82% | -360.3% | -40.71% | -35.2% | 66.78% | 122.82% | -1206.36% | 96.32% | 75.83% |
D&A (Non-Cash Add-back) | 1.32M | 1.85M | 3.52M | 2.73M | 2.13M | 2.38M | 2.21M | 3.56M | 4.3M | 3.25M |
EBIT | -7.57M | 3.86M | -22.92M | -29.69M | -38.46M | -13.81M | 299K | -33.39M | -6.47M | -10.77M |
Net Interest Income | -820K | -1.83M | -1.52M | -759K | 0 | -97K | -15K | -29K | -1.49M | -1.53M |
Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Interest Expense | 820K | 1.83M | 1.52M | 759K | 0 | 97K | 15K | 29K | -1.49M | 1.53M |
Other Income/Expense | -1.61M | -3.36M | -2.06M | -1.19M | -459K | 387K | -229K | 217K | -2.55M | -2.8M |
Pretax Income | -8.38M▲ 0% | 2.03M▲ 124.2% | -24.45M▼ 1303.6% | -30.45M▼ 24.6% | -38.46M▼ 26.3% | -13.9M▲ 63.9% | 284K▲ 102.0% | -33.42M▼ 11868.3% | -7.96M▲ 76.2% | -12.47M▲ 0% |
Pretax Margin % | -14.2% | 1.5% | -21.03% | -47.59% | -70.48% | -19.91% | 0.3% | -57.33% | - | 74.59% |
Income Tax | 134K | 754K | 1.39M | -521K | 167K | 184K | 374K | 226K | 0 | -10.4M |
Effective Tax Rate % | -1.6% | 37.12% | -5.68% | 1.71% | -0.43% | -1.32% | 131.69% | -0.68% | 0% | 83.38% |
Net Income | -8.52M▲ 0% | 1.28M▲ 115.0% | -25.83M▼ 2123.0% | -29.93M▼ 15.9% | -38.63M▼ 29.0% | -14.09M▲ 63.5% | -90K▲ 99.4% | -33.65M▼ 37286.7% | -20.66M▲ 38.6% | -14.78M▲ 0% |
Net Margin % | -14.43% | 0.94% | -22.22% | -46.77% | -70.78% | -20.17% | -0.1% | -57.72% | - | 88.36% |
Net Income Growth % | - | 114.99% | -2123.02% | -15.86% | -29.05% | 63.53% | 99.36% | -37286.67% | 38.61% | 51.21% |
Net Income (Continuing) | -8.52M | 1.28M | -25.83M | -29.93M | -38.63M | -14.09M | -90K | -33.65M | -7.96M | -12.34M |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -12.7M | 1000K |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EPS (Diluted) | -1495.71▲ 0% | -257.45▲ 82.8% | -138.87▲ 46.1% | -64.78▲ 53.4% | -40.81▲ 37.0% | -4.88▲ 88.0% | -0.02▲ 99.6% | -7.13▼ 33852.4% | -1.59▲ 77.7% | -1.17▲ 0% |
EPS Growth % | - | 82.79% | 46.06% | 53.35% | 37% | 88.04% | 99.57% | -33852.38% | 77.7% | -50.04% |
EPS (Basic) | -1495.71 | -257.45 | -138.87 | -64.78 | -40.81 | -4.88 | -0.02 | -7.13 | -28.58 | - |
Diluted Shares Outstanding | 10.27K | 34.47K | 186.04K | 462.09K | 946.46K | 2.89M | 4.29M | 4.72M | 13.01M | 12.65M |
Basic Shares Outstanding | 5.7K | 4.96K | 186.04K | 462.09K | 946.46K | 2.89M | 4.29M | 4.72M | 722.69K | 1.27M |
Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
SONM Balance Sheet
DNA X, Inc. (SONM) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 27.37M | 63.87M | 47.34M | 45.57M | 35.69M | 43.63M | 43.79M | 32.16M | 28.91M | 3.3M |
Cash & Short-Term Investments | 1.58M | 13.05M | 11.3M | 22.14M | 11.23M | 13.21M | 9.4M | 5.34M | 1.3M | 1.2M |
Cash Only | 1.58M | 13.05M | 11.3M | 22.14M | 11.23M | 13.21M | 9.4M | 5.34M | 1.3M | 1.2M |
Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts Receivable | 12.16M | 21.44M | 11.46M | 5.11M | 14.75M | 24.75M | 26.27M | 11.64M | 0 | 0 |
Days Sales Outstanding | 75.21 | 57.68 | 35.98 | 29.17 | 98.66 | 129.36 | 102.39 | 72.87 | - | -127.46 |
Inventory | 8.98M | 21.83M | 19.53M | 11.34M | 5.54M | 3.91M | 6.52M | 10.62M | 0 | 0 |
Days Inventory Outstanding | 84.69 | 90.99 | 87.21 | 84.88 | 42.02 | 24.52 | 32.01 | 80.13 | - | -468.6 |
Other Current Assets | 3.98M | 5.82M | 2.73M | 2.81M | 2.53M | 770K | 935K | 4.56M | 27.61M | 2.11M |
Total Non-Current Assets | 2.88M | 3.48M | 8.12M | 4.74M | 5.4M | 10.05M | 12.26M | 7.57M | 14.99M | 1.53M |
Property, Plant & Equipment | 724K | 1.07M | 1.44M | 843K | 534K | 234K | 126K | 227K | 0 | 0 |
Fixed Asset Turnover | 81.53x | 126.67x | 80.62x | 75.91x | 102.19x | 298.41x | 743.11x | 256.82x | - | -222.21x |
Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.24M | 1.24M |
Other Non-Current Assets | 2.16M | 2.41M | 6.68M | 3.9M | 4.87M | 9.82M | 12.13M | 7.35M | 12.31M | 1.53M |
Total Assets | 30.25M▲ 0% | 67.34M▲ 122.7% | 55.46M▼ 17.6% | 50.31M▼ 9.3% | 41.09M▼ 18.3% | 53.69M▲ 30.7% | 56.04M▲ 4.4% | 39.74M▼ 29.1% | 43.9M▲ 10.5% | 4.84M▲ 0% |
Asset Turnover | 1.95x | 2.01x | 2.10x | 1.27x | 1.33x | 1.30x | 1.67x | 1.47x | - | -0.53x |
Asset Growth % | - | 122.65% | -17.65% | -9.28% | -18.33% | 30.65% | 4.39% | -29.09% | 10.47% | -115.59% |
Total Current Liabilities | 28.03M | 48.2M | 27.61M | 20.47M | 20.98M | 32.06M | 32.15M | 43.74M | 48.03M | 4.32M |
Accounts Payable | 11.25M | 27.3M | 7.23M | 8.86M | 9.47M | 22.09M | 19.85M | 22.85M | 4.03M | 719K |
Days Payables Outstanding | 106.04 | 113.76 | 32.3 | 66.26 | 71.8 | 138.51 | 97.49 | 172.38 | 342.08 | -1.03K |
Short-Term Debt | 3.13M | 301K | 9.82M | 177K | 148K | 147K | 0 | 0 | 5.24M | 1.07M |
Deferred Revenue (Current) | 4.68M | 4.22M | 291K | 5K | 11K | 31K | 12K | 0 | 0 | 2.15M |
Other Current Liabilities | 7.49M | 13.3M | 8.39M | 9.16M | 9.46M | 5.5M | 10.03M | 13.67M | 38.76M | 954K |
Current Ratio | 0.98x | 1.33x | 1.71x | 2.23x | 1.70x | 1.36x | 1.36x | 0.74x | 0.60x | 0.76x |
Quick Ratio | 0.66x | 0.87x | 1.01x | 1.67x | 1.44x | 1.24x | 1.16x | 0.49x | 0.60x | 0.76x |
Cash Conversion Cycle | 53.85 | 34.91 | 90.88 | 47.79 | 68.88 | 15.37 | 36.91 | -19.38 | - | 430.7 |
Total Non-Current Liabilities | 11.73M | 14.02M | 2.32M | 1.43M | 1.48M | 1.58M | 1.53M | 1.7M | 2.6M | 600K |
Long-Term Debt | 7.55M | 13.21M | 362K | 185K | 66K | 0 | 0 | 0 | 0 | 0 |
Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 600K |
Other Non-Current Liabilities | 4.18M | 807K | 1.96M | 1.24M | 1.41M | 1.58M | 1.53M | 1.7M | 2.6M | 0 |
Total Liabilities | 39.76M | 62.22M | 29.93M | 21.9M | 22.46M | 33.64M | 33.67M | 45.44M | 50.63M | 4.92M |
Total Debt | 10.69M | 13.51M | 10.18M | 362K | 214K | 213K | 55K | 0 | 5.24M | 1.07M |
Net Debt | 9.1M | 461K | -1.11M | -21.78M | -11.02M | -13M | -9.34M | -5.34M | 3.93M | -123K |
Debt / Equity | - | 2.63x | 0.40x | 0.01x | 0.01x | 0.01x | 0.00x | - | - | -12.92x |
Debt / EBITDA | - | 1.86x | - | - | - | - | 0.02x | - | - | -0.17x |
Net Debt / EBITDA | - | 0.06x | - | - | - | - | -3.44x | - | - | 0.02x |
Interest Coverage | -9.23x | 2.11x | -15.06x | -39.12x | - | -142.33x | 19.93x | -1151.48x | -4.35x | -7.06x |
Total Equity | -9.51M▲ 0% | 5.13M▲ 153.9% | 25.52M▲ 397.7% | 28.41M▲ 11.3% | 18.63M▼ 34.4% | 20.05M▲ 7.6% | 22.37M▲ 11.6% | -5.7M▼ 125.5% | -6.73M▼ 18.0% | -83K▲ 0% |
Equity Growth % | - | 153.91% | 397.66% | 11.3% | -34.42% | 7.6% | 11.59% | -125.48% | -18.02% | -137.91% |
Book Value per Share | -926.75 | 148.78 | 137.20 | 61.48 | 19.68 | 6.94 | 5.22 | -1.21 | -0.52 | -0.01 |
Total Shareholders' Equity | -9.51M | 5.13M | 25.52M | 28.41M | 18.63M | 20.05M | 22.37M | -5.7M | -6.73M | -83K |
Common Stock | 1K | 15K | 20K | 66K | 19K | 41K | 43K | 5K | 1.23M | 5.74M |
Retained Earnings | -144.8M | -143.53M | -166.25M | -196.18M | -234.81M | -249.87M | -249.96M | -283.61M | -304.26M | -297.6M |
Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SONM Cash Flow Statement
DNA X, Inc. (SONM) cash flow — operating, investing & free cash flow history
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | -8.91M | 3.86M | -33.52M | -10.56M | -38.48M | -12.36M | -4.05M | -8.49M | -23.53M | -17.39M |
Operating CF Margin % | -15.09% | 2.85% | -28.84% | -16.5% | -70.51% | -17.7% | -4.33% | -14.56% | - | - |
Operating CF Growth % | - | 143.35% | -968.25% | 68.5% | -264.36% | 67.88% | 67.22% | -109.43% | -177.23% | -1511.26% |
Net Income | -8.52M | 1.28M | -25.83M | -29.93M | -38.63M | -14.09M | -90K | -33.65M | -20.66M | -14.78M |
Depreciation & Amortization | 1.32M | 1.85M | 3.52M | 2.73M | 2.13M | 2.38M | 2.21M | 3.54M | 4.3M | -1.05M |
Stock-Based Compensation | 104K | 252K | 6.31M | 1.09M | 1.08M | 1.55M | 1.5M | 1.52M | 1.54M | 14K |
Deferred Taxes | -284K | 140K | 109K | 21K | -35K | 0 | 0 | 0 | 0 | 0 |
Other Non-Cash Items | 928K | 1.47M | 3.25M | 1.5M | 2.27M | -869K | 644K | 9.79M | -3.62M | -28.45M |
Working Capital Changes | -2.45M | -1.13M | -20.88M | 14.04M | -5.3M | -1.33M | -8.31M | 10.3M | -5.09M | 6.22M |
Change in Receivables | -3.67M | -8.06M | 8.75M | 5.46M | -7.52M | -11.63M | -1.72M | -6.11M | -19.5M | -13.28M |
Change in Inventory | 3.37M | -12.85M | -809K | 7.49M | 4.18M | 1.63M | -2.61M | -4.99M | 3.85M | 7.08M |
Change in Payables | -3.35M | 16.05M | -20.07M | 1.49M | 617K | 11.65M | -1.28M | 14.31M | 9.53M | 12.43M |
Cash from Investing | -999K | -2.54M | -1.36M | -11K | -46K | -8K | -36K | -214K | 0 | 3.36M |
Capital Expenditures | -1.17M | -2.54M | -1.36M | -11K | -46K | -8K | -36K | -214K | 0 | 0 |
CapEx % of Revenue | 1.99% | 1.88% | 1.17% | 0.02% | 0.08% | 0.01% | 0.04% | 0.37% | - | 0% |
Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.36M |
Investments | - | - | - | - | - | - | - | - | - | - |
Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash from Financing | 4.42M | 10.15M | 33.13M | 21.41M | 27.61M | 14.35M | 272K | 4.65M | 19.49M | 13.11M |
Debt Issued (Net) | 4.59M | 1.86M | -3.69M | -4.15M | -148K | -67K | -147K | 591K | 5.82M | 8.08M |
Equity Issued (Net) | 0 | 8.29M | 38.47M | 25.57M | 27.7M | 14.41M | 419K | 4.01M | 13.67M | 5.02M |
Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Financing | -170K | -5K | -1.65M | -6K | 60K | 0 | 0 | 48K | 0 | 0 |
Net Change in Cash | -5.49M▲ 0% | 11.47M▲ 309.0% | -1.75M▼ 115.3% | 10.84M▲ 719.2% | -10.91M▼ 200.6% | 1.98M▲ 118.2% | -3.82M▼ 292.7% | -4.05M▼ 6.2% | -4.04M▲ 0.3% | -920K▲ 0% |
Free Cash Flow | -10.08M▲ 0% | 1.32M▲ 113.1% | -34.88M▼ 2750.4% | -10.57M▲ 69.7% | -38.52M▼ 264.4% | -12.37M▲ 67.9% | -4.09M▲ 66.9% | -8.7M▼ 112.8% | -23.53M▼ 170.4% | -17.39M▲ 0% |
FCF Margin % | -17.08% | 0.97% | -30% | -16.52% | -70.59% | -17.71% | -4.37% | -14.92% | - | 103.98% |
FCF Growth % | - | 113.06% | -2750.38% | 69.69% | -264.41% | 67.89% | 66.95% | -112.82% | -170.41% | 3.99% |
FCF per Share | -981.88 | 38.17 | -187.49 | -22.88 | -40.70 | -4.28 | -0.95 | -1.84 | -1.81 | -1.37 |
FCF Conversion (FCF/Net Income) | 1.05x | 3.02x | 1.30x | 0.35x | 1.00x | 0.88x | 45.02x | 0.25x | 1.14x | 1.18x |
Interest Paid | 306K | 546K | 1.04M | 260K | 0 | 97K | 15K | 29K | 945K | 221K |
Taxes Paid | 198K | 259K | 273K | 76K | 87K | 151K | 42K | 134K | 122K | 16K |
SONM Key Ratios
DNA X, Inc. (SONM) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | 24.9% | -168.55% | -110.99% | -164.23% | -72.85% | -0.42% | -403.74% | - | 668.17% |
Return on Invested Capital (ROIC) | 156.2% | -111.91% | -141.39% | -400.24% | -146.25% | 3.83% | -2544.55% | - | 2427.36% |
Gross Margin | 35.45% | 29.68% | 23.77% | 11.75% | 16.65% | 20.64% | 17.02% | - | 75.69% |
Net Margin | 0.94% | -22.22% | -46.77% | -70.78% | -20.17% | -0.1% | -57.72% | - | 88.36% |
Debt / Equity | 2.63x | 0.40x | 0.01x | 0.01x | 0.01x | 0.00x | - | - | -12.92x |
Interest Coverage | 2.11x | -15.06x | -39.12x | - | -142.33x | 19.93x | -1151.48x | -4.35x | -7.06x |
FCF Conversion | 3.02x | 1.30x | 0.35x | 1.00x | 0.88x | 45.02x | 0.25x | 1.14x | 1.18x |
Revenue Growth | 129.82% | -14.31% | -44.95% | -14.72% | 27.96% | 34.09% | -37.74% | -100% | -128.71% |
Related:SONM Dividend History·SONM Revenue History·SONM Price History·SONM P/E History·SONM Financial Ratios·SONM Institutional Holders
SONM SEC Filings & Documents
DNA X, Inc. (SONM) SEC filings — annual & quarterly reports (10-K, 10-Q)
SONM Frequently Asked Questions
DNA X, Inc. (SONM) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
DNA X, Inc. (SONM) reported $-16.7M in revenue for fiscal year 2025. This represents a 128% decrease from $59.0M in 2017.
DNA X, Inc. (SONM) saw revenue decline by 100.0% over the past year.
DNA X, Inc. (SONM) reported a net loss of $14.8M for fiscal year 2025.
Dividend & Returns
DNA X, Inc. (SONM) had negative free cash flow of $17.4M in fiscal year 2025, likely due to heavy capital investments.